Sports Medicine

, Volume 34, Issue 5, pp 307–316 | Cite as

Effects of Exercise, Diet and Weight Loss on High Blood Pressure

  • Simon L. Bacon
  • Andrew Sherwood
  • Alan Hinderliter
  • James A. Blumenthal
Review Article


High blood pressure (BP) is a major health problem in the US, affecting more than 50 million people. Although high BP is among the most common reasons for outpatient visits, BP control is often inadequate. It is well established that BP can be lowered pharmacologically in hypertensive individuals; however, anti-hypertensive medications are not effective for everyone, and may be costly and result in adverse effects that impair quality of life and reduce adherence. Moreover, abnormalities associated with high BP, such as insulin resistance and hyper-lipidaemia, may persist or may even be exacerbated by some anti-hypertensive medications. Consequently, there has been a great deal of interest in the development and application of behavioural interventions in the management of high BP.

The main behavioural interventions that are recommended to reduce BP are exercise and the Dietary Approaches to Stop Hypertension (DASH) diet. Weight loss is also recommended for BP reduction in overweight individuals. Exercise alone is associated with reductions of approximately 3.5 and 2.0mm Hg in systolic (SBP) and diastolic blood pressure (DBP), respectively. Patients fed a DASH diet (a diet high in low-fat dairy products and fibre, including fruits and vegetables) had reductions in SBP and DBP of 5.5 and 3.0mm Hg, respectively, compared with those consuming a standard US diet. Reductions of approximately 8.5mm Hg SBP and 6.5mm Hg DBP accompany weight loss of 8kg. In overweight hypertensive patients, a combined exercise and weight-loss intervention has been shown to decrease SBP and DBP by 12.5 and 7.9mm Hg, respectively.

There is evidence to suggest that these decreases in BP are associated with improvements in left ventricular structure and function, and peripheral vascular health. Both exercise training and weight loss have been shown to decrease left ventricular mass and wall thickness, reduce arterial stiffness and improve endothelial function. These data support the role of behavioural interventions in the treatment of patients with elevations in BP.


Systolic Blood Pressure Diastolic Blood Pressure High Blood Pressure Leave Ventricular Hypertrophy Arterial Stiffness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors would like to thank the National Institutes of Health, Bethesda, MD, for providing financial support from Grants HL 49572 and HL 59672. The authors have no conflicts of interest that are directly relevant to the content of this review.


  1. 1.
    Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560–72Google Scholar
  2. 2.
    Kochanek KD, Smith BL, Anderson RN. Deaths: preliminary data for 1999. Natl Vital Stat Rep 2001; 49: 1–48Google Scholar
  3. 3.
    Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary disease, part 2: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–38PubMedGoogle Scholar
  4. 4.
    MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–74PubMedGoogle Scholar
  5. 5.
    Dengel DR, Galecki AT, Hagberg JM, et al. The independent and combined effects of weight loss and aerobic exercise on blood pressure and oral glucose tolerance in older men. Am J Hypertens 1988; 11: 1405–12Google Scholar
  6. 6.
    Pratley RE, Hagberg JM, Dengel DR, et al. Aerobic exercise training-induced reductions in abdominal fat and glucose-stimulted insulin responses in middle-age and older men. J Am Geriatric Soc 2000; 48: 1055–61Google Scholar
  7. 7.
    Smutok MA, Reece C, Kokkinos PF, et al. Aerobic versus strength training for risk factor intervention in middle-aged men at high risk for coronary heart disease. Metabolism 1993; 42: 177–84PubMedGoogle Scholar
  8. 8.
    Wallace MB, Mills BD, Browning CL. Effects of cross-training on markers of insulin resistance/hyperinsulinemia. Med Sci Sports Exerc 1997; 29: 1170–5PubMedGoogle Scholar
  9. 9.
    Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173–8PubMedGoogle Scholar
  10. 10.
    Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–6PubMedGoogle Scholar
  11. 11.
    Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Ann Intern Med 1969; 71(1): 89–105PubMedGoogle Scholar
  12. 12.
    American College of Sports Medicine. Position stand: physical activity, physical fitness, and hypertension. Med Sci Sports Exerc 1994; 25: i–xGoogle Scholar
  13. 13.
    Arroll B, Beaglehole R. Does physical activity lower blood pressure: a critical review of clinical trials. J Clin Epidemiol 1992; 45: 439–47PubMedGoogle Scholar
  14. 14.
    Blumenthal JA, Sherwood A, Gullette ECD, et al. Biobehavioral approaches to the treatment of essential hypertension. J Consult Clin Psychol 2002; 70: 569–89PubMedGoogle Scholar
  15. 15.
    Halbert JA, Silagy CA, Finucane P, et al. The effectiveness of exercise training in lowering blood pressure: a meta-analysis of randomised controlled trials of 4 weeks or longer. J Hum Hypertens 1997; 11: 641–9PubMedGoogle Scholar
  16. 16.
    Kelley GA. Aerobic exercise and resting blood pressure among women: a meta-analysis. Prev Med 1999; 28: 264–75PubMedGoogle Scholar
  17. 17.
    Kelley G, McClellan P. Antihypertensive effects of aerobic exercise: a brief meta-analytic review of randomized controlled trials. Am J Hypertens 1994; 7: 115–9PubMedGoogle Scholar
  18. 18.
    Linden W, Chambers L. Clinical effectiveness of non-drug treatment for hypertension: a meta-analysis. Ann Behav Med 1994; 16: 35–45Google Scholar
  19. 19.
    Siegel WC, Blumenthal JA. The role of exercise in the prevention and treatment of hypertension. Ann Behav Med 1991; 13: 23–30Google Scholar
  20. 20.
    Tipton CM. Exercise training and hypertension: an update. In: Holloszy JO, editor. Exercise and sport sciences reviews. Baltimore (MD): Williams & Wilkins, 1991: 447–505Google Scholar
  21. 21.
    Paffenbarger RS, Thorbe MC, Wing AL. Chronic disease in former college students, VIII: characteristics in youth predisposing to hypertension in later years. Am J Epidemiol 1968; 88: 25–32PubMedGoogle Scholar
  22. 22.
    Lee I-M, Hsieh S, Paffenbarger RS. Exercise intensity and longevity in men: the Harvard Alumni Health Study. JAMA 1995; 273: 1179–84PubMedGoogle Scholar
  23. 23.
    Paffenbarger RS, Wing AL, Hyde RT, et al. Physical activity and incidence of hypertension in college alumni. Am J Epidemiol 1983; 117: 245–57PubMedGoogle Scholar
  24. 24.
    Blair SN, Goodyear NN, Gibbons LW, et al. Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA 1984; 252: 487–90PubMedGoogle Scholar
  25. 25.
    Whelton SP, Chin A, Xin X, et al. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized controlled trials. Ann Intern Med 2002; 136: 493–503PubMedGoogle Scholar
  26. 26.
    Hagberg JM, Park J-J, Brown MD. The role of exercise training in the treatment of hypertension. Sports Med 2000; 30: 193–206PubMedGoogle Scholar
  27. 27.
    Keil U, Liese A, Filipiak B, et al. Alcohol, blood pressure and hypertension. Novartis Found Symp 1998; 216: 125–44PubMedGoogle Scholar
  28. 28.
    World Hypertension League. Alcohol and hypertension: implications for management: a consensus statement by the World Hypertension League. J Hum Hypertens 1991; 5: 1854–6Google Scholar
  29. 29.
    Maheswaran R, Gill JS, Davies P, et al. High blood pressure due to alcohol: a rapidly reversible effect. Hypertension 1991; 17: 787–92PubMedGoogle Scholar
  30. 30.
    Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III: analysis of data from trials of salt reduction. BMJ 1991; 302: 819–24PubMedGoogle Scholar
  31. 31.
    Cutler JA, Follmann D, Elliott P, et al. An overview of randomized trials of sodium restriction and blood pressure. Hypertension 1991; 17Suppl. I: 127–33Google Scholar
  32. 32.
    Sullivan JM. Salt sensitivity: definition, conception, methodology, and long-term issues. Hypertension 1991; 17Suppl. I: 161–8Google Scholar
  33. 33.
    Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure: results for 24 hour urinary sodium and potassium excretion. BMJ 1988; 297: 319–28Google Scholar
  34. 34.
    Linas SL. The role of potassium in the pathogenesis and treatment of hypertension. Kidney Int 1991; 39: 771–86PubMedGoogle Scholar
  35. 35.
    Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure: meta-analysis of randomized clinical trials. JAMA 1997; 277: 1624–32PubMedGoogle Scholar
  36. 36.
    Hamet P, Mongeau E, Lambert J, et al. Interactions among calcium, sodium, and alcohol intake as determinants of blood pressure. Hypertension 1991; 17Suppl. I: 1150–4Google Scholar
  37. 37.
    Allender PS, Cutler JA, Follmann D, et al. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Arch Intern Med 1996; 124: 825–31Google Scholar
  38. 38.
    Cutler JA, Brittain E. Calcium and blood pressure: an epidemiologic perspective. Am J Hypertens 1990; 3: 137–146SGoogle Scholar
  39. 39.
    Kawano Y, Matsuoka H, Takishita S, et al. Effects of magnesium supplementation in hypertensive patients: assessment by office home and ambulatory blood pressures. Hypertension 1998; 32: 260–5PubMedGoogle Scholar
  40. 40.
    Appel LJ, Moore TJ, Obarzanek E, et al. The effect of dietary patterns on blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH) clinical trial. N Engl J Med 1997; 336: 1117–24PubMedGoogle Scholar
  41. 41.
    Windhauser M, Karanja N, McCullough M, et al. Dietary adherence in the DASH multi-center controlled feeding trial. J Am Diet Assoc 1999; 99: S76–s83PubMedGoogle Scholar
  42. 42.
    Conlin PR, Chow D, Miller ER, et al. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Hypertens 2000; 13: 949–55PubMedGoogle Scholar
  43. 43.
    Sacks FM, Svetkey LP, Vollmer WM, et al. A clinical trial of the effects on blood pressure of reduced dietary sodium and the DASH dietary pattern. N Engl J Med 2001; 344: 3–10PubMedGoogle Scholar
  44. 44.
    McCarron DA. DASH-Sodium trial: where are the data? Am J Hypertens 2003; 16: 92–4PubMedGoogle Scholar
  45. 45.
    Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hypertension Prevention phase II. Arch Intern Med 1997; 157: 657–67Google Scholar
  46. 46.
    Svetkey LP, Simons-Morton D, Vollmer WM, et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 1999; 159: 285–93PubMedGoogle Scholar
  47. 47.
    Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003; 289: 2083–93Google Scholar
  48. 48.
    Jeffery RW. Weight management and hypertension. Ann Behav Med 1991; 13: 18–22Google Scholar
  49. 49.
    Pérez-Stable EJ, Coates TJ, Baron RB, et al. Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension. J Gen Intern Med 1995; 10: 419–28PubMedGoogle Scholar
  50. 50.
    Gordon NF, Scott CB, Levine BD. Comparison of single versus multiple lifestyle interventions: are the antihypertensive effects of exercise training and diet-induced weight loss additive? Am J Cardiol 1997; 79: 763–7PubMedGoogle Scholar
  51. 51.
    Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of Mild Hypertension Study: final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993; 270: 713–24PubMedGoogle Scholar
  52. 52.
    Langford HG, Davis BR, Blaufox D, et al. Effect of drug and diet treatment of mild hypertension on diastolic blood pressure: The TAIM Research Group. Hypertension 1991; 17: 210–7PubMedGoogle Scholar
  53. 53.
    Mulrow CD, Chiquette E, Angel L, et al. Dieting to reduce body weight for controlling hypertension in adults. Cochrane Hypertension Group. Available in the Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 3. Oxford: Update Software, 2002Google Scholar
  54. 54.
    Staessen J, Fagard R, Amery A. The relationship between body weight and blood pressure. J Hum Hypertens 1998; 2: 207–17Google Scholar
  55. 55.
    MacMahon S, Cutter J, Brittain E, et al. Obesity and hypertension: epidemiological and clinical issues. Eur Heart J 1987; 8Suppl. B: 57–70PubMedGoogle Scholar
  56. 56.
    Blumenthal JA, Sherwood A, Gullette EC, et al. Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic, and hemodynamic functioning. Arch Intern Med 2000; 160: 1947–58PubMedGoogle Scholar
  57. 57.
    Wilfrey DE, Brownell KD. Physical activity and diet in weight loss. In: Dishman RK, editor. Advances in exercise adherence. Champaign (IL): Human Kinetics Press, 1994Google Scholar
  58. 58.
    Wilmore JH. Body composition in sport and exercise: directions for future research. Med Sci Sports Exerc 1983; 15: 21–31PubMedGoogle Scholar
  59. 59.
    Bouchard C, Bray GA, Hubbard VS. Basic and clinical aspects of regional fat distribution. Am J Clin Nutr 1990; 52: 946–50PubMedGoogle Scholar
  60. 60.
    Craighead LW, Blum MD. Supervised exercise in behavioral treatment for moderate obesity. Behav Ther 1989; 20: 49–59Google Scholar
  61. 61.
    Dahlkoetter J, Callahan EJ, Linton J. Obesity and the unbalanced energy equation. J Consult Clin Psychol 1979; 47: 898–905PubMedGoogle Scholar
  62. 62.
    Stalonas PM, Johnson WG, Christ M. Behavior modification for obesity. J Consult Clin Psychol 1978; 46: 463–9PubMedGoogle Scholar
  63. 63.
    Hagan RD, Upton SJ, Wong L, et al. The effects of aerobic conditioning and/or caloric restriction in overweight men and women. Med Sci Sports Exerc 1986; 18: 87–94PubMedGoogle Scholar
  64. 64.
    Hammond IW, Devereux RB, Alderman MH, et al. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol 1988; 12: 996–1004PubMedGoogle Scholar
  65. 65.
    Messerli FH, Sundgaard-Riise K, Reisin ED, et al. Dimorphic cardiac adaption to obesity and arterial hypertension. Ann Intern Med 1983; 99: 757–61PubMedGoogle Scholar
  66. 66.
    de Simone G, Devereux RB, Roman MJ, et al. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 1994; 23: 600–6PubMedGoogle Scholar
  67. 67.
    Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Study. Ann Intern Med 1989; 110: 101–8PubMedGoogle Scholar
  68. 68.
    Liao Y, Cooper RS, McGee DL, et al. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA 1995; 273: 1592–7PubMedGoogle Scholar
  69. 69.
    Balogum MO, Dunn FG. Regression of left ventricular hypertrophy in patients with hypertension. J Hum Hypertens 1990; 4: 29–34Google Scholar
  70. 70.
    Dunn FG, Bastian B, Lawrie TDV, et al. Effect of blood pressure control on left ventricular hypertrophy in patients with essential hypertension. Clin Sci 1980; 59: 4415–35Google Scholar
  71. 71.
    Franz IW, Ketelhut R, Behr U, et al. Long term studies on regression of left ventricular hypertrophy. J Cardiovasc Pharmacol 1991; 127: S87–93Google Scholar
  72. 72.
    Julien J, Dufloux MA, Prasquier R, et al. Effects of captopril and minoxidil on left ventricular hypertrophy. J Am Coll Cardiol 1990; 16: 137–42PubMedGoogle Scholar
  73. 73.
    Schmeider RE. Risk reduction following regression of cardiac hypertrophy. Clin Exp Hypertens 1990; 12: 903–16Google Scholar
  74. 74.
    Shahi M, Thom S, Poulter N, et al. Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic function. Lancet 1990; 336: 458–61PubMedGoogle Scholar
  75. 75.
    Kokkinos PF, Narayan P, Colleran JA, et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med 1995; 333: 1462–7PubMedGoogle Scholar
  76. 76.
    Hinderliter A, Sherwood A, Gullette ECD, et al. Exercise and weight loss reduce left ventricular hypertrophy in overweight patients with mild hypertension. Arch Intern Med 2002; 162: 1333–9PubMedGoogle Scholar
  77. 77.
    MacMahon SW, Wilcken DEL, Macdonald GJ. The effect of weight reduction on left ventricular mass: a randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 1986; 314: 334–9PubMedGoogle Scholar
  78. 78.
    Maron BJ. Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 1986; 7: 190–203PubMedGoogle Scholar
  79. 79.
    Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med 2001; 161: 1183–92PubMedGoogle Scholar
  80. 80.
    Verdecchia P, Schillaci G, Borgioni C, et al. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32: 983–98PubMedGoogle Scholar
  81. 81.
    Mancia G, Giannattasio C, Failla M, et al. Systolic blood pressure and pulse pressure: role of 24-h mean values and variability in the determination of organ damage [published erratum appears in J Hypertens 2000; 18: 121]. J Hypertens 1999; 17Suppl. 5: S55–61Google Scholar
  82. 82.
    O’Rourke MF, Staessen JA, Vlachopoulos C, et al. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002; 15: 426–44PubMedGoogle Scholar
  83. 83.
    Sjostrom CD, Peltonen M, Sjostrom L. Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study. Obes Res 2001; 9: 188–95PubMedGoogle Scholar
  84. 84.
    Resnick LM, Militianu D, Cunnings AJ, et al. Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium. Hypertension 1997; 30: 654–9PubMedGoogle Scholar
  85. 85.
    Giannattasio C, Failla M, Grappiolo A, et al. Arterial distensibility in hypercholesterolemia and diabetes. Clin Hemorheol Microcirc 1999; 21: 233–9PubMedGoogle Scholar
  86. 86.
    Giannattasio C, Failla M, Grappiolo A, et al. Progression of large artery structural and functional alterations in Type I diabetes. Diabetologia 2001; 44: 203–8PubMedGoogle Scholar
  87. 87.
    Westerbacka J, Vehkavaara S, Bergholm R, et al. Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes 1999; 48: 821–7PubMedGoogle Scholar
  88. 88.
    de Simone G, McClelland R, Gottdiener JS, et al. Relation of hemodynamics and risk factors to ventricular-vascular interactions in the elderly: the Cardiovascular Health Study. J Hypertens 2001; 19: 1893–903PubMedGoogle Scholar
  89. 89.
    Gosse P, Jullien V, Jarnier P, et al. Reduction in arterial distensibility in hypertensive patients as evaluated by ambulatory measurement of the QKD interval is correlated with concentric remodeling of the left ventricle. Am J Hypertens 1999; 12: 1252–5PubMedGoogle Scholar
  90. 90.
    White WB. The systolic blood pressure versus pulse pressure controversy. Am J Cardiol 2001; 87: 1278–81PubMedGoogle Scholar
  91. 91.
    Cameron JD, Rajkumar C, Kingwell BA, et al. Higher systemic arterial compliance is associated with greater exercise time and lower blood pressure in a young older population. J Am Geriatr Soc 1999; 47: 653–6PubMedGoogle Scholar
  92. 92.
    Terenzi TJ. An alteration in arterial compliance associated with elevated aerobic fitness. J Manipulative Physiol Ther 2000; 23: 27–31PubMedGoogle Scholar
  93. 93.
    Schmitz KH, Arnett DK, Bank A, et al. Arterial distensibility and physical activity in the ARIC study. Med Sci Sports Exerc 2001; 33: 2065–71PubMedGoogle Scholar
  94. 94.
    Tanaka H, Dinenno FA, Monahan KD, et al. Aging, habitual exercise, and dynamic arterial compliance. Circulation 2000; 102: 1270–5PubMedGoogle Scholar
  95. 95.
    Parnell MM, Holst DP, Kaye DM. Exercise training increases arterial compliance in patients with congestive heart failure. Clin Sci 2002; 102: 1–7PubMedGoogle Scholar
  96. 96.
    Ferrier KE, Waddell TK, Gatzka CD, et al. Aerobic exercise training does not modify large-artery compliance in isolated systolic hypertension. Hypertension 2001; 38: 222–6PubMedGoogle Scholar
  97. 97.
    Bragulat E, de la Sierra A, Antonio MT, et al. Endothelial dysfunction in salt-sensitive essential hypertension. Hypertension 2001; 37: 444–8PubMedGoogle Scholar
  98. 98.
    Panza JA, Quyyumi AA, Brush Jr JE, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–7PubMedGoogle Scholar
  99. 99.
    Taddei S, Virdis A, Mattei P, et al. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21: 929–33PubMedGoogle Scholar
  100. 100.
    Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191–6PubMedGoogle Scholar
  101. 101.
    Millgard J, Hagg A, Kahan T, et al. Left ventricular hypertrophy is associated with an attenuated endothelium-dependent vasodilation in hypertensive men. Blood Press 2000; 9: 309–14PubMedGoogle Scholar
  102. 102.
    Perticone F, Maio R, Ceravolo R, et al. Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients. Circulation 1999; 99: 1991–6PubMedGoogle Scholar
  103. 103.
    Schiffrin EL, Park JB, Intengan HD, et al. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000; 101: 1653–9PubMedGoogle Scholar
  104. 104.
    Taddei S, Virdis A, Ghiadoni L, et al. Role of endothelin in the control of peripheral vascular tone in human hypertension. Heart Fail Rev 2001; 6: 277–85PubMedGoogle Scholar
  105. 105.
    Vogel R, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol 1997; 79: 350–4PubMedGoogle Scholar
  106. 106.
    Cuevas AM, Guasch V, Castillo O, et al. A high-fat diet induces and red wine counteracts endothelial dysfunction in human volunteers. Lipids 2000; 35: 143–8PubMedGoogle Scholar
  107. 107.
    DeSouza CA, Shapiro LF, Clevenger CM, et al. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 2000; 102: 1351–7PubMedGoogle Scholar
  108. 108.
    Gokce N, Vita JA, Bader DS, et al. Effect of exercise on upper and lower extremity endothelial function in patients with coronary artery disease. Am J Cardiol 2002; 90: 124–7PubMedGoogle Scholar
  109. 109.
    Linke A, Schoene N, Gielen S, et al. Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training. J Am Coll Cardiol 2001; 37: 392–7PubMedGoogle Scholar
  110. 110.
    Higashi Y, Sasaki S, Kurisu S, et al. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. Circulation 1999; 100: 1194–202PubMedGoogle Scholar
  111. 111.
    Maeda S, Miyauchi T, Kakiyama T, et al. Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans. Life Sci 2001; 69: 1005–16PubMedGoogle Scholar
  112. 112.
    Chandrruangphen P, Collins P. Exercise-induced suppression of postprandial lipemia: a possible mechanism of endothelial protection? Arterioscler Thromb Vasc Biol 2002; 22: 1239PubMedGoogle Scholar

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  • Simon L. Bacon
    • 1
  • Andrew Sherwood
    • 1
  • Alan Hinderliter
    • 2
  • James A. Blumenthal
    • 1
  1. 1.Department of Psychiatry and Behavioral SciencesDUMCDurhamUSA
  2. 2.Department of MedicineUniversity of North Carolina HospitalChapel HillUSA

Personalised recommendations